|1||NCT03817125||Recruiting||Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention||
||Other / Industry||
||30||All||18 Years and older (Adult, Older Adult)||NCT03817125||PICI0014||MCGRAW||January 28, 2019||February 2021||February 2022||January 25, 2019||September 9, 2019||
|2||NCT01295827||Completed||Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)||
||1260||All||18 Years and older (Adult, Older Adult)||NCT01295827||P07990
|KEYNOTE-001||March 4, 2011||November 5, 2018||December 11, 2018||February 15, 2011||April 2, 2019|
† Study has passed its completion date and status has not been verified in more than two years.